C. Ganellin

J. Schwartz, H. Stark, C. Ganellin, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.

Holger Stark, J. Schwartz, H. Stark, 2002, Journal of medicinal chemistry.

Protean agonism at histamine H3 receptors in vitro and in vivo

J. Schwartz, H. Stark, S. Crochet, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.

J. Schwartz, H. Stark, J. Arrang, 2004, Bioorganic & medicinal chemistry.

Constitutive activity of the recombinant and native histamine H3 receptor

J. Schwartz, H. Stark, J. Arrang, 2003 .

Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor.

J. Schwartz, H. Stark, J. Arrang, 2003, Journal of neural transmission. Supplementum.

Medicinal Chemistry: The Role of Organic Chemistry in Drug Research

C. Ganellin, S. Roberts, 1985 .

Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues.

C. Ganellin, J. Narenjkar, E. Assem, 2004, European journal of pharmacology.

Characterization and inhibition of a cholecystokinin-inactivating serine peptidase

J. Schwartz, P. B. Bishop, C. Ganellin, 1996, Nature.

Chemistry and Structure-Activity Relationships of H2-Receptor Antagonists

C. Ganellin, 1978 .

Further studies on bis-charged tetraazacyclophanes as potent inhibitors of small conductance Ca(2+)-activated K+ channels.

D. Jenkinson, C. Ganellin, Donglai Yang, 2013, European journal of medicinal chemistry.

Bis‐Quinolinium Cyclophanes: 6,10‐Diaza‐3(1,3),8(1,4)‐dibenzena‐1,5(1,4)‐diquinolinacyclodecaphane (UCL 1684), the First Nanomolar, Non‐Peptidic Blocker of the Apamin‐Sensitive Ca2+‐Activated K+ Channel.

D. Jenkinson, C. Ganellin, D. Galanakis, 1998 .

Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channel.

D. Jenkinson, C. Ganellin, D. Galanakis, 1998, Journal of medicinal chemistry.

Discrimination between subtypes of apamin‐sensitive Ca2+‐ activated K+ channels by gallamine and a novel bis‐quaternary quinolinium cyclophane, UCL 1530

D. Jenkinson, C. Ganellin, P. M. Dunn, 1996, British journal of pharmacology.

Dictionary of Pharmacological Agents

Dj Triggle, C. Ganellin, Charon Robin Ganellin, 1996 .

Chemical differentiation of histamine H1- and H2-receptor agonists.

G. J. Durant, C. Ganellin, M. Parsons, 1975, Journal of medicinal chemistry.

CHEMICAL DIFFERENTIATION OF HISTAMINE H1- AND H2-RECEPTOR AGONISTS

G. J. Durant, C. Ganellin, M. Parsons, 1976 .

Chapter Twenty-Four - Glossary of Terms Used in Medicinal Chemistry Part II (IUPAC Recommendations 2013)

J. Proudfoot, P. Erhardt, C. Ganellin, 2013 .

Glossary of terms used in medicinal chemistry. Part II (IUPAC Recommendations 2013)

J. Proudfoot, P. Erhardt, C. Ganellin, 2013 .

Search for the pharmacophore in prazosin for Transport-P.

C. Ganellin, P. Zunszain, S. Al-Damluji, 2005, Bioorganic & medicinal chemistry.

Pioneer and Analogue Drugs

C. Ganellin, J. Fischer, D. Rotella, 2012 .

Medicinal Chemistry as a Scientific Discipline in Industry and Academia: Personal Reflections

C. Ganellin, 2007 .

BF2.649, A NON-IMIDAZOLE INVERSE AGONIST/ANTAGONIST AT THE HUMAN HISTAMINE H3 RECEPTOR: PRECLINICAL PHARMACOLOGY

H. Stark, F. Gbahou, V. Bertaina-Anglade, 2006 .

Discovery of Pitolisant, the First Marketed Histamine H3‐Receptor Inverse Agonist/Antagonist for Treating Narcolepsy*

J. Schwartz, H. Stark, C. Ganellin, 2018 .

Dipole moment in relation to hydrogen receptor histamine antagonist activity for cimetidine analogs

R. C. Young, J. C. Emmett, R. Mitchell, 1986 .

Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors

W. Duncan, G. J. Durant, C. Ganellin, 1978, Nature.

Chemical constitution and prototropic equilibria in structure — activity analysis

C. Ganellin, 1977 .

Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities.

J. Schwartz, H. Stark, Yuan H. Zhao, 2003, Bioorganic & medicinal chemistry.

Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.

J. Schwartz, H. Stark, J. Arrang, 2002, Journal of medicinal chemistry.

Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.

J. Schwartz, H. Stark, J. Arrang, 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.

J. Schwartz, P. B. Bishop, O. Peschard, 2000, Journal of medicinal chemistry.

On the Concept of a Bivalent Pharmacophore for SKCa Channel Blockers: Synthesis, Pharmacological Testing, and Radioligand Binding Studies on Mono‐, Bis‐, and Tris‐quinolinium Compounds

D. Jenkinson, C. Ganellin, D. Galanakis, 1996, Archiv der Pharmazie.

Dictionary of drugs

C. Ganellin, C. Pattenden, F. Macdonald, 1990 .

Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.

J. Schwartz, P. B. Bishop, C. Ganellin, 2005, Journal of medicinal chemistry.

Correlation between log POCT/H2O and pKB estimates for a series of muscarinic and histamine H2‐receptor antagonists

J. Black, R. Mitchell, N. Shankley, 1988, British journal of pharmacology.

The dielectric properties of seven polar amidine-containing compounds of biological interest

E. Grant, C. Ganellin, M. J. Graham, 1985 .

Calculations on Unstable Conformations of Histamine and Methylhistamines

W. Richards, C. Ganellin, 1974 .

S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.

J. Schwartz, J. Arrang, C. Ganellin, 1992, The Journal of pharmacology and experimental therapeutics.

Histamine H3 receptors : novel ligands and responses

J. Schwartz, M. Dam, J. Arrang, 1992 .

Isocytosine H2-receptor histamine antagonists II. Synthesis and evaluation of biological activity at histamine H1- and H2-receptors of 5-(heterocyclyl)methylisocytosines

G. J. Durant, C. Ganellin, M. Parsons, 1989 .

Definition and Antagonism of Histamine H2-receptors

J. Black, W. Duncan, C. Ganellin, 1972, Nature.

Molecular Asymmetry of Olefins. I. Resolution of trans-Cyclooctene1-3

C. Ganellin, H. W. Johnson, A. C. Cope, 1963 .

Cimetidine—A Non-Thiourea H2-Receptor Antagonist

Graham J. Durant, J. C. Emmett, W. Duncan, 1975 .

Sulphur-methylene isosterism in the developent of metiamide, a new histamine H2-receptor antagonist

J. C. Emmett, J. Black, G. J. Durant, 1974, Nature.

An Efficient New Synthesis of Racemic Cetiedil and a Novel Route to α-Ketocarboxylic Acids Utilising Mild Conditions

C. Ganellin, C. Roxburgh, A. Thorpe, 2007 .

Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.

J. C. Emmett, C R Ganellin, G. J. Durant, 1977, Journal of medicinal chemistry.

Characterization and development of cimetidine as a histamine H2-receptor antagonist

J. C. Emmett, W. Duncan, G. J. Durant, 1978 .

Compounds affecting the central nervous system. I. 4-Piperidones and related compounds.

C. Ganellin, R. Spickett, 1965, Journal of medicinal chemistry.

A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.

J. Schwartz, B. Bang-Andersen, C. Ganellin, 1996, Journal of medicinal chemistry.

Molecular features of the prazosin molecule required for activation of Transport-P.

C. Ganellin, S. Al-Damluji, Joaquim Fernando Mendes da Silva, 2008, Bioorganic & medicinal chemistry.

Chapter Two – Chemistry and Structure—Activity Relationships of Drugs Acting at Histamine Receptors

C. Ganellin, C. Robin Ganellin, 1982 .

4-(ω-(Alkyloxy)alkyl)-1H-imidazole Derivatives as Histamine H3 Receptor Antagonists/Agonists

J. Schwartz, H. Stark, J. Arrang, 2004 .

Pharmacology of Histamine Receptors

C. R. Ganellin, C. Ganellin, M. Parsons, 1982 .

Potential histamine H2-receptor antagonists. 3. Methylhistamines.

J. C. Emmett, G. J. Durant, C. Ganellin, 1976, Journal of medicinal chemistry.

Some chemical aspects of histamine H2-receptor antagonists.

J. C. Emmett, G. J. Durant, C. Ganellin, 1976, Federation proceedings.

Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists.

R Griffiths, R. C. Young, C R Ganellin, 1988, Journal of medicinal chemistry.

Dictionary of drugs: chemical data, structures, and bibliographies

J. Elks, C. R. Ganellin, C. Ganellin, 2016 .

Discovery of the cholesterol absorption inhibitor, ezetimibe

C. Ganellin, 2013 .

Isocytosine H2-receptor histamine antagonists. I: Oxmetidine and related compounds

J. C. Emmett, G. J. Durant, C. Ganellin, 1988 .

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.

J. Schwartz, H. Stark, J. Arrang, 2000, Bioorganic & medicinal chemistry letters.

New 3,4-O-isopropylidene derivatives of d- and l-glucopyranosides

C. Ganellin, S. Thaisrivongs, J. Cai, 1995 .

Zwitterionic analogues of cimetidine as H2 receptor antagonists.

R. C. Young, R. Mitchell, C. Ganellin, 1987, Journal of medicinal chemistry.

The synthesis of tertiary arylalkylamines from aryl Grignard reagents.

C. Ganellin, P. Bavin, H. F. Ridley, 1966, Journal of medicinal chemistry.

Stereochemical studies of chiral H-1 antagonists of histamine: the resolution, chiral analysis, and biological evaluation of four antipodal pairs.

A. Drake, C. Ganellin, A. Casy, 1992, Chirality.

An Efficient New Synthesis of Racemic Cetiedil and a Novel Route to α-Ketocarboxylic Acids Utilizing Mild Conditions

C. Ganellin, C. Roxburgh, A. Thorpe, 2007 .

Dimaprit, [S-[3-(N,N-dimethylamino)propyl]isothiourea]. A highly specific histamine H2-receptor agonist. Part 2. Structure-activity considerations

G. J. Durant, C. Ganellin, M. Parsons, 1977, Agents and Actions.

Resolution of trans-Cycloöctene; Confirmation of the Asymmetry of cis-trans-1,5-Cycloöctadiene

C. Ganellin, H. W. Johnson, A. C. Cope, 1962 .

Search for Histamine H3 Receptor Ligands with Combined Inhibitory Potency at Histamine N‐Methyltransferase: ω‐Piperidinoalkanamine Derivatives

J. Schwartz, H. Stark, J. Arrang, 2004, Archiv der Pharmazie.

(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors.

J. Schwartz, H. Stark, C. Ganellin, 2000, Bioorganic & medicinal chemistry.

Compounds affecting the central nervous system. IV. Substituted 2-benzyl-3-dialkylaminoalkylindenes and related compounds.

C. Ganellin, H. F. Ridley, R. Spickett, 1967, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of dequalinium analogues as K+ channel blockers. Investigations on the role of the charged heterocycle.

D. Jenkinson, C. Ganellin, D. Galanakis, 1995, Journal of medicinal chemistry.

14 N and 2H quadrupole double resonance in substituted imidazoles

C. Ganellin, John A. S. Smith, P. Bavin, 1983 .

Chapter 10 Histamine Receptors

C. Ganellin, 1979 .

Partial structures of ketoconazole as modulators of the large conductance calcium-activated potassium channel (BK(Ca)).

C. Ganellin, E. Power, David C. H. Benton, 2006, Bioorganic & medicinal chemistry letters.

Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR).

S. Mani, C. Ganellin, T. Zvyaga, 2008, Bioorganic & medicinal chemistry letters.

Partial Structures of Ketoconazole as Modulators of the Large Conductance Calcium‐Activated Potassium Channel (BKCa).

C. Ganellin, E. Power, David C. H. Benton, 2006 .

Optimizing Drug Therapy by Analogues

J. Proudfoot, C. Ganellin, J. Fischer, 2010 .

Metiamide—An orally active histamine H2-receptor antagonist

J. C. Emmett, J. Black, W. Duncan, 2005, Agents and Actions.

Histamine-induced inhibition of lymphocyte proliferation and lysosomal enzyme release from polymorphs may not be mediated via H1- or H2-receptors

C. Ganellin, K. Milliner, M. R. Vickers, 1982, Agents and Actions.

Indane and indene derivatives of biological interest.

C. Ganellin, 1967, Advances in drug research.

High constitutive activity of native H3 receptors regulates histamine neurons in brain

Holger Stark, J. Schwartz, H. Stark, 2000, Nature.

Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists.

J. Schwartz, H. Stark, C. Ganellin, 2002, Bioorganic & medicinal chemistry.

Benzophenone Derivatives and Related Compounds as Potent Histamine H3‐Receptor Antagonists and Potential PET/SPECT Ligands

J. Schwartz, H. Stark, J. Arrang, 2001, Archiv der Pharmazie.

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.

J. Schwartz, M. Jouvet, H. Stark, 1998, The Journal of pharmacology and experimental therapeutics.

Different antagonist binding properties of human and rat histamine H3 receptors.

J. Schwartz, H. Stark, W. Sippl, 2001, Bioorganic & medicinal chemistry letters.

The histamine H2 receptor agonist impromidine: synthesis and structure-activity considerations.

G. J. Durant, C. Ganellin, M. Parsons, 1985, Journal of medicinal chemistry.

Naming of substituted histamines

J. Black, C. Ganellin, 2005, Experientia.

Potential HIV protease inhibitors: Preparation of di-N-alkylated 2-, 6-, and 2,6-aminodeoxy-derivatives of d-glucose by direct displacement and by a novel reductive-alkylation procedure

C. Ganellin, S. Thaisrivongs, J. Cai, 1997 .

Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.

J. Schwartz, H. Stark, J. Arrang, 2000, Journal of medicinal chemistry.

Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity.

J. Schwartz, H. Stark, C. Ganellin, 1999, Journal of medicinal chemistry.

New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.

J. Schwartz, H. Stark, J. Arrang, 2000, Journal of medicinal chemistry.

Benzophenone Derivatives and Related Compounds as Potent Histamine H3‐Receptor Antagonists and Potential PET/SPECT Ligands.

J. Schwartz, H. Stark, J. Arrang, 2001 .

Imetit and N-methyl derivatives. The transition from potent agonist to antagonist at histamine H3 receptors.1

J. Schwartz, J. Arrang, B. Bang-Andersen, 1992 .

Radiosynthesis and biodistribution of two potential antagonists of cerebral histamine H3 receptors for PET studies: [18F]FUB 272 and [11C]UCL 1829

C. Crouzel, J. Schwartz, H. Stark, 1998 .

Relative concentrations of zwitterionic and uncharged species in catecholamines and the effect of N-substituents.

C R Ganellin, C. Ganellin, 1977, Journal of medicinal chemistry.

Search for the pharmacophore of the K+ channel blocker, apamin

D. Jenkinson, C. Ganellin, P. M. Dunn, 1991 .

Molecule--receptor specificity.

W. Richards, C. Ganellin, R. Clarkson, 1975, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Structure-activity studies of pyridinylalkyl-isocytosine H1-receptor antihistamines and identification of an active conformation.

G. J. Durant, C. Ganellin, R. Ife, 1991, Farmaco.

Analogues of Triprolidine: Structural Influences upon Antihistamine Activity

C. Ganellin, A. Casy, C. Upton, 1992, The Journal of pharmacy and pharmacology.

[125I]Iodobolpyramine, a highly sensitive probe for histamine H1-receptors in guinea-pig brain.

M. Bouthenet, N. Salès, J. Schwartz, 1986, European journal of pharmacology.

Iodobolpyramine and other iodinated derivatives as ligands for detecting histamine H1 receptors

J. Schwartz, M. Korner, C. Ganellin, 1987 .

Metiamide — An orally active histamine H2-receptor antagonist

J. C. Emmett, J. Black, W. Duncan, 1973, Agents and Actions.

Proceedings: The pharmacology of cimetidine, a new histamine H2-receptor antagonist.

Graham J. Durant, J. W. Black, J. Black, 1975 .

The pharmacology of cimetidine, a new histamine H2-receptor antagonist.

J W Black, C R Ganellin, J. Black, 1975, British journal of pharmacology.

Characterization of histamine H1-receptor binding peptides in guinea pig brain using [125I]iodoazidophenpyramine, an irreversible specific photoaffinity probe.

J. Schwartz, M. Korner, C. Ganellin, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Sedation and histamine H1‐receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene

A. Nicholson, C. Ganellin, C. Turner, 1991, British journal of pharmacology.

Personal reflections on Sir James Black (1924–2010) and histamine

C. Ganellin, 2010, Inflammation Research.

Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SKCa)

D. I. Fletcher, D. Jenkinson, C. Ganellin, 2007 .

Dimaprit-[S-[3-(N,N-dimethylamino)propyl]isothiourea] —A highly specific histamine H2-receptor agonist. Part 1. Pharmacology

G. J. Durant, C. Ganellin, M. Parsons, 1977, Agents and Actions.

Cimetidine and Other Histamine H 2 -Receptor Antagonists

C. Ganellin, R. Brimblecombe, 1987 .

CYANOGUANIDINE‐THIOUREA EQUIVALENCE IN THE DEVELOPMENT OF THE HISTAMINE H2‐RECEPTOR ANTAGONIST, CIMETIDINE

J. C. Emmett, G. J. Durant, H. D. Prain, 1977 .

SULPHUR-METHYLENE ISOSTERISM IN THE DEVELOPMENT OF METIAMIDE, A NEW HISTAMINE H2-RECEPTOR ANTAGONIST

Graham J. Durant, J. C. Emmett, J. W. Black, 1974 .

Selective impairment of atrioventricular conduction by 2-(2-pyridyl)-ethylamine and 2-(2-thiazolyl)-ethylamine, two histamine H1-receptor agonists.

C. Ganellin, H. Willens, R. Levi, 1975, European journal of pharmacology.

Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channel.

D. Jenkinson, C. Ganellin, D. Galanakis, 2000, Journal of medicinal chemistry.

Predicting the brain-penetrating capability of histaminergic compounds.

C R Ganellin, C. Ganellin, J A Calder, 1994, Drug design and discovery.

Dipole moment in relation to H2 receptor histamine antagonist activity for cimetidine analogues.

R. C. Young, J. C. Emmett, C R Ganellin, 1986, Journal of medicinal chemistry.

Bis-quinolinium cyclophanes: toward a pharmacophore model for the blockade of apamin-sensitive SKCa channels in sympathetic neurons.

C. Ganellin, D. Galanakis, P. M. Dunn, 2004, Bioorganic & medicinal chemistry letters.

Bis-quinolinium cyclophanes: A novel class of potent blockers of the apamin-sensitive Ca2+-activated K+ channel

D. Jenkinson, C. Ganellin, D. Galanakis, 1997 .

Synthesis and qsar of dequalinium analogues AS K+ channel blockers. investigations on the role of the 4-amino group

D. Jenkinson, C. Ganellin, D. Galanakis, 1995 .

Histamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

H. Haas, J. Schwartz, R. Thurmond, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Analogue-based Drug Discovery: FISCHER: ANALOGUE-BASED DRUG DISCOVERY O-BK

C. Ganellin, J. Fischer, 2006 .

An approach to the design of brain-penetrating histaminergic agonists

R Griffiths, R. C. Young, R. Mitchell, 1993 .

Synthesis and Authentication of Iodoazidophenpyramine, a Photoaffinity Reporter Ligand Previously used for Histamine H1‐Receptor Labelling

C. Ganellin, G. Sorba, W. Tertiuk, 1995 .

Calculation of conformational free energy of histamine

C. R. Ganellin, W. G. Richards, W. Richards, 1974 .

Conformation of histamine derivatives. 3. A relationship between conformation and pharmacological activity.

C. Ganellin, 1973, Journal of medicinal chemistry.

Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.

J. Schwartz, H. Stark, K. Kieć‐Kononowicz, 1999, Journal of medicinal chemistry.

The Slow Afterhyperpolarization: A Target of β1-Adrenergic Signaling in Hippocampus-Dependent Memory Retrieval

C. Ganellin, S. Thomas, M. Ouyang, 2013, The Journal of Neuroscience.

Enhancement of Hippocampal Pyramidal Cell Excitability by the Novel Selective Slow-Afterhyperpolarization Channel Blocker 3-(Triphenylmethylaminomethyl)pyridine (UCL2077)

D. G. Haylett, M. Shah, C. Ganellin, 2006, Molecular Pharmacology.

Icotidine, an antagonist of histamine at both H1 and H2 receptors.

C. Ganellin, M. Parsons, R. Ife, 1986, New England and regional allergy proceedings.

Dimaprit—[S-[3-(N,N-dimethylamino)propyl]isothiourea]—A highly specific histamine H2-receptor agonist. Part 1, pharmacology

G. J. Durant, C. Ganellin, M. Parsons, 2005, Agents and Actions.

DNA binding cationic bolasomes with delocalized charge center : A structure-activity relationship study

V. Torchilin, V. Weissig, C. Ganellin, 2001 .

Conformation of histamine derivatives. 1. Application of molecular orbital calculations and nuclear magnetic resonance spectroscopy.

W. Richards, C. Ganellin, E. S. Pepper, 1973, Journal of medicinal chemistry.

Conformation of histamine derivatives. 2. Molecular orbital calculations of preferred conformations in relation to dual receptor activity.

W. Richards, C. Ganellin, G. Port, 1973, Journal of medicinal chemistry.

Non-basic histamine H1-antagonists. I: Synthesis and biological evaluation of some substituted 2-(2-pyridylaminoalkylamino) pyrimidones and related compounds

G. J. Durant, C. Ganellin, M. Parsons, 1989 .

Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes.

S Athmani, C R Ganellin, D. Jenkinson, 2001, Journal of medicinal chemistry.

Histamine receptors in GtoPdb v.2021.3

H. Haas, J. Schwartz, R. Thurmond, 2021, IUPHAR/BPS Guide to Pharmacology CITE.

Characterization and development of cimetidine as a histamine H2-receptor antagonist.

J. C. Emmett, W. Duncan, G. J. Durant, 1978, Gastroenterology.

The pressor activity of burimamide: A relationship between chemical constitution and pressor activity of burimamide and related histamine H2-receptor antagonists

C. Ganellin, D. Owen, 1977, Agents and Actions.

Relaxation methods applied to engineering problems V. Conformal transformation of a region in plane space

R. Southwell, C. Ganellin, 1940, Philosophical Transactions of the Royal Society of London. Series A, Mathematical and Physical Sciences.

The dipole moments of 1,3-dimethylthiourea, 1,3-dimethyl-2-cyanoguanidine and 1,1-bis-methylamino-2-nitroethene in a aqueous solution

E. Grant, C. Ganellin, M. J. Graham, 1982 .

Potential histamine H2-receptor antagonists. 3. Methylhistamines.

J. C. Emmett, G. J. Durant, C. Ganellin, 1976, Journal of medicinal chemistry.

Vocational training for medicinal chemists: views from industry.

L. Mitscher, C. Ganellin, W Busse, 1996, European journal of medicinal chemistry.

Chapter 33. Educating Medicinal Chemists

J. Topliss, L. Mitscher, C. Ganellin, 1995 .

Clotrimazole analogues: effective blockers of the slow afterhyperpolarization in cultured rat hippocampal pyramidal neurones

M. Shah, C. Ganellin, D. Haylett, 2001, British journal of pharmacology.

Structures of nine histamine H2 antagonists related to N-cyano-N'-methyl-N-[4-(2-pyridyl)butyl]guanidine

G. J. Durant, C. Ganellin, D. Watkin, 1993 .

bis-Quinolinium cyclophanes: 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane (UCL 1848), a highly potent and selective, nonpeptidic blocker of the apamin-sensitive Ca(2+)-activated K(+) channel.

D. Jenkinson, C. Ganellin, D. Galanakis, 2000, Journal of medicinal chemistry.

Synthesis, molecular modeling, and K+ channel-blocking activity of dequalinium analogues having semirigid linkers.

C. Ganellin, D. Galanakis, P. M. Dunn, 1996, Journal of medicinal chemistry.

Synthesis and quantitative structure-activity relationship of a novel series of small conductance Ca(2+)-activated K+ channel blockers related to dequalinium.

C. Ganellin, D. Galanakis, P. M. Dunn, 1996, Journal of medicinal chemistry.

Performance monitoring by the supplementary eye ® eld

J. Schall, V. Stuphorn, T. L. Taylor, 2000 .

Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives.

J. Schwartz, H. Stark, J. Arrang, 2005, Die Pharmazie.

Modulation of GABAA receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis‐9,10‐octadecenoamide (cOA)

G. Lees, C. Ganellin, M. Edwards, 1998, British journal of pharmacology.

Bis-quinolinium Cyclophanes: A Novel Class of Potent Blockers of the Apamin-Sensitive Ca2+-Activated K+ Channel.

D. Jenkinson, C. Ganellin, B. Beckwith-Hall, 1997 .

Synthesis and pharmacological testing of dequalinium analogues as blockers of the apamin-sensitive Ca(2+)-activated K+ channel: variation of the length of the alkylene chain.

C. Ganellin, D. Galanakis, P. M. Dunn, 1996, Journal of Medicinal Chemistry.